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Abstract
Background—Evidence on the role of age-disparate partnerships in high HIV-infection rates 
among young women in sub-Saharan Africa remains inconclusive. This study examined the HIV-
infection risk associated with age-disparate partnerships among 15–24 year-old women in a hyper-
endemic setting in South Africa.
Methods—Face-to-face questionnaire, and laboratory HIV and viral load data were collected 
during 2014–2015 among a representative sample (15–49 years-old) in KwaZulu-Natal. The 
association between age-disparate partnerships (age-difference ≥5 years) and HIV-status among 
15–24 year-old women (N=1459) was assessed using multiple logistic regression analyses. Data 
from the male sample on all on-going partnerships (N=1229) involving 15–24 year-old women 
were used to assess whether young women’s age-disparate male partners were more likely to have 
a viral load ≥1000 copies/ml, a marker of HIV-infection risk.
Results—Women reporting an age-disparity in any of their three recent partnerships were more 
likely to test HIV-positive compared to women with only age-similar partners (aOR:1.58, 95%CI:
1.20–2.09,p<0.01). Among partnerships men reported with 15–24 year old women, the age-
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disparate male partners were more likely to be HIV-positive and have a viral load ≥1000 
copies/mL (aOR:2.05, 95%CI:1.30–3.24,p<0.01) compared to age-similar partners. Results were 
similar for each category of age-disparity: partners 5–9 years older (aOR:2.01, 95%CI:1.18–
3.43,p=0.010) and those ≥10 years older (aOR:2.17, 95%CI:1.01–4.66,p=0.048).
Conclusions—Results indicate that age-disparate partnerships increase young women’s HIV 
risk, although conclusive evidence was not ascertained. Interventions addressing risk from age-
disparate sexual partnering, including expanding antiretroviral treatment among older partners, 
may help to reduce HIV-incidence among young women.
Keywords
age-mixing; HIV prevention; key population; HIV infection risk; sub-Saharan Africa; 
antiretroviral therapy
Introduction
Young women in sub-Saharan Africa remain at the epicentre of the HIV epidemic, with 
persistent high HIV incidence.1,2 In South Africa, incidence rates for young black African 
women are among the highest of any population globally.3 A better understanding of factors 
that influence young women’s HIV infection risk is critical for the success of efforts to 
reduce the burden of disease among this vulnerable population. Conflicting evidence has 
generated uncertainty about the role that age-disparate partnerships (i.e., those in which the 
male partner is 5 or more years older) play in young women’s HIV risk, and consequently 
the value of HIV prevention interventions aimed specifically at reducing risk within such 
partnerships.4–12
Two compounding factors give plausibility to the hypothesis that age-disparate partnerships 
increase HIV risk for young women. First, HIV prevalence among men increases steeply 
with age until approximately 40 years old.3 Unless young women are able to select older 
HIV-negative partners, age-disparate male partners are more likely to be HIV-positive than 
younger partners and therefore pose greater HIV-infection risk. Second, several studies have 
documented a range of riskier sexual behaviours within age-disparate partnerships, including 
condomless sex,13–15 transactional sex,16 and concurrent sexual partnering.17
Conversely, differences by age in the uptake of HIV testing and antiretroviral therapy (ART) 
among men could theoretically mitigate HIV-infection risk within age-disparate 
partnerships. HIV testing is positively associated with age,18–21 and older HIV-positive men 
are more likely to have been diagnosed than their younger counterparts. Moreover, older 
men are also more likely to link to HIV care and treatment post diagnosis.22–24 
Consequently, while age-disparate partners of young women are more likely to be HIV 
positive, a greater percentage could be on ART and virally supressed. As viral suppression 
reduces the onward transmission of HIV,25,26 age-disparate partners may, therefore, not pose 
additional HIV infection risk for young women if the proportion of men who are HIV 
positive with a suppressed HIV viral load is similar within age-similar and age-disparate 
partnerships.
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The potential for ART to mitigate risk from age-disparate partnerships will likely vary across 
time and location as ART uptake, retention and adherence among men and age-differentials 
in ART coverage change. Contextual factors relating to ART coverage may, for example, 
partially explain why age-disparate partnerships among young women in The Africa Centre 
for Population Health cohort in rural KwaZulu-Natal were not found to increase HIV risk.10 
Men in the study region are part of an ongoing demographic surveillance system that 
includes regular HIV-testing and referral to care.27 Potential geographic and temporal effects 
on the relationship between age-disparate partnerships and young women’s HIV risk 
highlights the importance of regular monitoring in different contexts.
In this study we assess the association between age-disparate partnerships and HIV status 
among 15–24 year old women in a high burden region of South Africa. Second, we explore 
the biological plausibility of the hypothesis that age-disparate partnerships increase risk for 
young women by examining HIV status and viral load among men who partner with 15–24 
year old women. Specifically, this analysis examines whether the proportion of young 
women’s partners with a viral load ≥1000 copies/mL (i.e., a marker of individuals who pose 
an HIV-infection risk) differs between age-disparate and age-similar partnerships.
Methods
Data
This study used data from the baseline survey conducted within the HIV Incidence 
Provincial Surveillance System (HIPSS) from June 2014 to June 2015.28 This cross-
sectional household-based survey was conducted in two sub-districts (Vulindlela (rural) and 
Greater Edendale (urban)) of the uMgungundlovu district in KwaZulu-Natal, South Africa. 
Households were randomly selected using two-stage random sampling methods. First 
enumeration areas (EA), the primary sampling unit, were selected and then households were 
drawn systematically in selected EAs using a serpentine pattern from a random starting 
location. One individual per household, within the age range 15–49 years, was randomly 
selected from a roster of eligible household members. The sample comprised 9812 
individuals. Venous blood samples were collected for HIV antibody and viral load tests from 
all participants. A face-to-face questionnaire was administered to collect data on, inter alia, 
demographics, socioeconomic status, and health related information. Details on participants’ 
first and three most recent sexual partners, including an estimated start date of each 
relationship were recorded. Participants were also asked the date of their most recent HIV 
test and the test result.
The study was approved by the Biomedical Research Ethics Committee, University of 
KwaZulu-Natal, (BF269/13), the Centers for Disease Control and Prevention (CDC) of the 
United States of America, and by the KwaZulu-Natal Provincial Department of Health in 
South Africa (HRKM 08/14). Eligible participants provided informed written consent prior 
to study enrolment. All study procedures followed were in accordance with the ethical 
standards of the Helsinki Declaration of 1975, as revised in 2000.
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Measures
Dependent variables—HIV testing was done using fourth generation HIV enzyme 
immunoassays to test for HIV antibodies and antigens using enzyme Biomerieux 
Vironostika Uniform II Antigen / Antibody Microelisa system (BioMérieux, Marcy I’Etoile, 
France) and HIV 1/2 Combi Roche Elecys (Roche Diagnostics, Penzberg, Germany). 
Positive tests were confirmed with a Western-Blot (Biorad assay, Bio-Rad Laboratories, 
Redmond, WA 98052, USA). Viral load among HIV-positive participants was measured 
using Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 v2.0 assay (CAP/CTM 
HIV-1 V2.0). All serology and viral load tests were performed by an accredited laboratory 
(via the South African National Accreditation System) according to the manufacturers’ 
manuals and were validated in the laboratories that were conducting the testing. Two binary 
dependent variables were created using laboratory data. The first identified individuals who 
tested HIV-positive, with the reference category representing all HIV-negative individuals. 
The second variable identified individuals who tested HIV-positive and had a viral load 
≥1000 copies/ml, with the reference category representing HIV-negative individuals, and 
HIV-positive individuals who had a viral load <1000 copies/mL. A viral load of ≥1000 
copies/mL was chosen as an indicator of individuals who pose an HIV-infection risk as 
male-to-female HIV transmission is rare below this level.29,30
Age-disparate variables—All sexually active respondents were asked the age of their 
first and three most recent sexual partners. Based on the UNAIDS definition,31 and 
consistent with the literature,4,7,9,10,32 age-disparate partnerships were identified as those in 
which the male partner was 5 or more years older. Partnerships in which women were >2 
years older than their partner were rare (e.g., only 0.6% (n=9) of the most recent 
partnerships reported by 15–24 year old women) and were coded as age-similar partnerships 
since these partnerships are not assumed to carry additional risk for young women.
For the analyses of HIV risk among 15–24 year old women, three separate binary measures 
of age-disparate partnering were created. The first variable was created to identify women 
who reported age-disparity in their most recent partnership. As partnership age disparities in 
previous, partnerships may have influenced HIV risk, we expanded the definition of the first 
measure with a second variable that identified women who reported an age-disparity in any 
of their three most recent partnerships. Furthermore, a third age-disparate measure was 
created by included all available partnership data to identify woman who reported an age-
disparity in their first-ever partnership or any of their three most recent partnerships. There is 
the potential for selection bias in analyses based on the third measure as a result of 414 
(26%) participants missing data regarding first-ever partnerships, participants’ age at first 
sex, or the partner’s age.
For each measure of age-disparate partnering we excluded data among HIV-positive women 
on partnerships (n=142) in which the start date of the partnership occurred after the reported 
date of an HIV-positive test. These partnerships were unrelated to HIV infection. The age-
disparate measures for these analyses were therefore based on data from all partnerships 
prior to a self-reported HIV-positive diagnosis.
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Analysis
All analyses were weighted to take into account the complex multi-level study design of the 
survey and to adjust for non-response. We adjusted standard errors for clustering at the 
enumeration area level to account for all potential within-cluster error correlation.33 All 
analyses were conducted using Stata 14 (Stata Corporation LP, College Station, TX).
HIV status among young women—Analyses of the association between age-disparate 
partnerships and HIV risk among young women were based on data collected from 15–24 
year old women who provided information on at least one sexual partner. Differences in the 
prevalence of HIV by partnership type (age-similar vs age-disparate) were assessed in 
bivariate analysis using two-sample equality of proportions tests. Multiple logistic regression 
models (odds ratios presented) were used to assess the association between HIV status and 
age-disparate partnerships among 15–24 year old women. Separate models were created 
using the three age-disparate measures as the key independent variable of interest. All 
models controlled for factors that could be correlated with both the dependent variable and 
the formation or dissolution of age-disparate partnerships (past and present). We did not 
control for factors that theoretically may be influenced by age-disparate partnerships, such 
as condom use, but are unlikely to be a factor explaining the existence of these partnerships. 
Control variables in all models included age of the woman (years); education (Grade 12 
completed or not); having always lived in the area; a household asset index (count of assets 
from 0–14); monthly household income; number of lifetime sexual partners; HIV-testing 
history (no, yes) and number of useful sources of HIV information exposed to during the 
previous 12 months (0–16).
HIV prevalence and viral load among men in partnerships with young women
—To assess whether older male partners of young women represent a higher infection risk, 
our second analysis used data on all ongoing partnerships (i.e., participants reported that the 
sexual relationship had not ended) men reported with a woman 15-to-24 years old. Given the 
HIPSS data are representative of the total sampled population, our assumption is that these 
partnerships represent all partnerships involving 15-to-24 year-old women in the study 
region. The men in these partnerships would therefore be a good proxy for the partners of all 
15-to-24 year-old women in the area. In other words, each of the partnerships reported by 
men represents one 15-to-24 year-old women. Accordingly, using these partnerships as 
individual data for 15-to-24 year-old women, the laboratory data on the men in each 
partnership provide HIV data on each male partner of 15-to-24 year-old women.
Two-sample equality of proportions tests were used to compare the percentage of HIV-
positive male partners, and HIV-positive male partners with a viral load ≥1000 copies/ml, in 
age-disparate and age-similar partnerships. Multiple logistic regression models were used to 
assess the association between partnership type and HIV status and viral load ≥1000 
copies/mL of male partners, and controlled for the age of the female partner (in years from 
15 to 24).
As intergenerational partnerships (i.e., those with an age-gap between partners of 10 or more 
years) have been a specific target of HIV prevention campaigns in South Africa,34 we 
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repeated our analysis among men to compare HIV prevalence and viral load among age-
similar male partners to two categories of age-disparate partners: 1) men 5–9 years older, 
and 2) men 10 or more years older.
Results
Sample of 15–24 year-old women
A total of 1459 women aged 15-to-24 years old provided data on at least one sexual 
partnership meeting the inclusion criteria for our analyses (see Table 1). The majority (69%) 
were 20–24 years old. Thirty-two percent reported that their most recent partnership 
involved a partner five or more years older than them (i.e., age-disparate). Forty-two percent 
reported at least one age-disparate partner either in any of their three most recent 
partnerships or in their first-ever partnership. HIV prevalence was 29% (95% CI: 26%-3%) 
among these women.
Sample of men in partnerships with 15–24 year-old women
A total of 1079 men reported ongoing partnerships with a woman 15–24 years old (see Table 
1). The majority of men (63%) were under 25 years old and few were older than 34 (3.7%). 
HIV prevalence was 15% (95% CI: 12%–18%) among men in the study population. These 
men reported 1229 ongoing partnerships with a woman 15–24 years old, with 104 men 
reporting more than one ongoing relationship. Among these partnerships, 26% where 
characterised as age-disparate by study definitions. The male partner was 5–9 years older in 
19% of partnerships and 10 or more years older in 7% of all partnerships.
HIV status among young women
For all age-disparate measures, bivariate and multiple logistic regression analyses (Table 2) 
showed that women who reported age-disparate partnerships were significantly more likely 
to have HIV than women who only reported age-similar partnerships. Bivariate analysis 
(Table 2, columns 1 and 2) indicated that HIV prevalence was 12 percentage points higher 
among women who reported an age-disparity in any of their three most recent partnerships 
(37% vs 25%; OR: 1.75, 95% CI: 1.35–2.28, p<0.01) compared to women who did not 
report an age-disparity with any partner. Results were substantively similar after controlling 
for potential confounders, such as number of lifetime sexual partners reported (Table 2, 
Column 3). According to data on the three most recent partnerships, the odds of a woman 
having HIV (aOR:1.58, 95% CI: 1.20–2.09, p<0.01) were greater in age-disparate 
partnerships.
HIV prevalence and viral load among men in partnerships with young women
Among the 1229 ongoing partnerships men reported with a woman 15–24 years old, 
unadjusted logistic regression analyses showed that age-disparate male partners were 
significantly more likely to be HIV-positive (27% vs 11%; OR: 2.97, 95% CI: 1.87–4.73, 
p<0.01) than age-similar male partners. Compared to age-similar partners, age-disparate 
male partners were also significantly more likely to be HIV-positive with a viral load ≥1000 
(17% vs 9%; OR: 2.11, 95% CI: 1.35–3.30, p<0.01). Similar results were found in the 
multiple logistic regression analyses (Table 3, Models 1 and 3). Age-disparate male partners 
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of young women were more likely to be HIV-positive with a viral load ≥1000 copies/mL 
(aOR:2.05, 95% CI:1.30–3.24, p<0.01) compared to age-similar partners (Table 3, Model 3).
Models 2 and 4 (Table 3) display the associations between the outcome measures and two 
categories of age-disparate male partners: men 5–9 years older and men 10+ years older. 
Compared to male partners in the age-similar partnerships, men 5–9 years older (aOR:2.29, 
95% CI:1.37–3.82, p<0.01) and men 10 or more years older (aOR:5.39, 95% CI:2.54–11.44, 
p<0.01) than their female partners were more likely to be HIV positive (Model 2). 
Compared to age-similar male partners, male partners in both categories of age-disparate 
partnerships were more likely to be HIV-positive with a viral load ≥1000 copies/mL (Model 
4): men 5–9 years older (aOR:2.01, 95% CI:1.18–3.43, p=0.010); men 10+ years older 
(aOR:2.17, 95% CI:1.01–4.66, p=0.048).
The similar size of the odds ratios in Model 4 for men 5–9 years older and men 10+ years 
older than their partner indicates that HIV-risk within these different partnerships may be 
similar after taking ART into account. The reduction in the size of the coefficient for men 
10+ years older than their partners from Models 2 to 4 (aOR:5.39 to 2.17) is consistent with 
additional study findings (see Table S2, Supplemental Digital Content 2) of a positive 
relationship between age among HIV-positive men and reporting being on ART (aOR:1.13, 
p<0.01). Moreover, among the HIV-positive men in our sample, only 22% of those who 
reported a partner 5–9 years younger than themselves had a viral load <1000 copies/mL 
compared to 50% of men who reported a partnership with a 10+ year age difference. These 
data indicate that older HIV-positive men were more likely to be on ART and virally 
suppressed.
Discussion
With persistent high HIV incidence among young women in sub-Saharan Africa there is a 
growing need to understand the factors that increase HIV risk among this population. In this 
article we provide evidence on the role age-disparate partnerships play in HIV-infection risk 
among 15–24 year old women in a high prevalence setting in South Africa. Consonant with 
other studies in Southern Africa,9,10,16 a substantial proportion of women in this study had 
age-disparate partners. Based on all the measures of age-disparate partnering we employed, 
evidence indicates an elevated HIV risk among women in age-disparate partnerships.
Moreover, results indicate biological plausibility for a positive association between age-
disparate partnerships and HIV-infection risk among young women. Older male partners of 
young women were not only more likely to be HIV-positive, but also more likely to be HIV-
positive and have a viral load ≥1000 copies/ml – a marker of partners who pose an HIV-
infection risk – compared to age-similar partners. These findings, in conjunction with 
several studies showing that age-disparate partnerships involve more risky sexual behaviour,
13,14,16,35,36
 point to an increased HIV-infection risk for young women in age-disparate 
partnerships.
However, results provide evidence that current patterns of ART uptake among men in this 
population could mitigate HIV-infection risk for young (15-to-24 year-old) women in age-
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disparate partnerships involving men 10 or more years older than their female partners 
(defined as intergenerational partnerships). Consistent with other studies,23 our data 
indicated that older HIV-positive men in our sample were more likely to be on ART than 
younger HIV-positive men. Consequently, while intergenerational male partners of young 
women had the highest HIV prevalence, findings suggest that young women with 
intergenerational male partners had a similar likelihood of having an infectious HIV-positive 
partner (i.e. a partner with a detectable viral load) than young women with partners 5–9 
years older than them. These findings suggest that while age-disparate partnerships in 
general may increase young women’s HIV risk, ART could mitigate the additional 
biological risk posed by intergenerational partnerships. In other words, in terms of the 
biological risk of HIV infection, the distinction between different types of age-disparate 
partnerships could be less relevant.
These findings indicate how variation by age among men in the uptake of an intervention 
that reduces the probability of onward transmission of HIV could affect the dynamics 
between age-disparate partnering and HIV risk for young women. It is also theoretically 
possible that variation in age in the uptake of interventions that reduce the likelihood of HIV 
infection for men, such as voluntary medical male circumcision, will change the relative risk 
that age-disparate partnerships and intergenerational partnerships pose for young women. In 
contexts with a larger proportion of young men circumcised compared to older men, for 
example, the HIV risk associated with age-disparate partners may be large for young 
women. The potential for the relationship between age-disparate partnering and HIV risk for 
young women, and women of other ages, to vary according to differential uptake of HIV 
services by age among men indicates the importance of further research in different 
contexts. Given the potential for geographic and temporal variation, the external validity of 
findings on the relationship between age-disparate partnerships and HIV-infection risk 
should be considered carefully.
These results should be interpreted in the context of the study limitations. While the use of 
biomedical data reduces the potential for social desirability bias on the key dependent 
variables, it is possible that social desirability bias, recall bias and incorrect knowledge 
might have resulted in miss-reporting of partnerships,37 and partner age.38 There is also the 
potential for selection bias in the analysis of HIV-status among women that includes data on 
first-ever partnerships in the measure of age-disparate partnering. This is due to a large 
amount of missing data on first-ever partnerships, participants’ age at first sex, or the 
partner’s age. In addition, we do not have data on the timing of HIV-infection among women 
and, therefore, do not know in which partnership HIV-infections occurred. There is the 
potential that some women who had age-disparate partners also engaged in high-risk sex 
with age-similar partners, and the HIV risk was associated with the age-similar rather than 
the age-disparate partner.
In analyses using partnership data reported by men on ongoing partnerships with a 15–24 
year-old women, we also do not have data on the timing of HIV-infection among HIV-
positive men. Accordingly, we do not know which men acquired HIV from the young 
women reported in the partnerships. There is potential for bias in our analyses if the 
proportion of men who acquired HIV from the partnerships reported in our data differed 
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between men in age-similar and age-disparate partnerships. If for example, a greater 
percentage of men in the age-disparate partnerships compared to those in the age similar 
partnerships acquired HIV within the reported partnership, which is possible as condomless 
sex is often more common in age-disparate partnerships, then our findings provide an 
overestimation of young women’s risk of HIV exposure from age-disparate partnerships. In 
addition, our analyses of male partners is based on the assumption that the partnerships 
reported by men in our sample represent all partnerships involving 15-to-24 year-old women 
in the study region. However, data on partnerships between 15-to-24 year-old women in the 
study region and men outside the study region are missing, and some partnerships reported 
by men are likely to be with young women from other regions. There is the potential for bias 
if the relationship between HIV-prevalence and age among male partners from other regions 
differs from that among the male partners living in the study region.
Overall, our results help to reduce the uncertainty in the literature by providing evidence to 
support the argument that age-disparate partnerships could elevate young women’s HIV risk. 
Our results are consistent with a phylogenetic transmission network analysis conducted 
using a sub-sample of participants from the HIPSS study that identified a cycle of HIV 
transmission driven by high rates of new HIV infections in adolescent girls and young 
women from men who were on average eight years older.39 The corollary of our findings, 
especially in high HIV-prevalence settings, is that interventions to reduce HIV infection risks 
associated with age-disparate partnerships may help to prevent new infections among young 
women and break this cycle of transmission. Our results highlight the importance of early 
diagnosis and treatment of HIV-positive men in age-disparate partnerships with young 
women as an integral component of the treat-all strategy for HIV prevention.40
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Table 1
Characteristics of 15–24 year old women in the study population and of men who reported at least one on-
going partnership with a 15–24 year old woman
Women 15–24 years
old who reported a
sexual partnership
(N=1459)
Men in partnerships
with 15–24 year old
women (N=1079)
Individual level data
Black African 100% 100%
Age (mean) 20.7 [20.6–20.9] 23.5 [23.1–23.8]
Age categories
   15–19 31% [28–34] 20% [17–23]
   20–24 69% [66–72] 43% [39–47]
   25–29 - 27% [24–31]
   30–34 - 6% [4–8]
   35–39 - 3% [1–4]
   40–49 - 0.7% [0.2–1]
Secondary school complete 56% [53–60] 54% [49–58]
Household monthly income
   <R500 16% [13–20] 18% [14–21]
   R501–R2500 49% [45–53] 44% [39–48]
Age-disparate (5+ year gap)#
   Last partner1 32% [28–35] na Φ
   Any of last 3 partners2 36% [32–40] na Φ
   1st or any of last 3 partners^,3 42% [37–46] na Φ
HIV+ 29% [26–32] 15% [12–18]
Partnership level data N=1229
Age-disparate (5+ age gap) na 26% [22–30]
Age-disparate (5–9 year gap) na 19% [16–23]
Age-disparate (10+ year gap) na 7% [4–9]
95% Confidence Intervals in brackets.
na: Not applicable for this analysis.
Φ
This figure has not been calculated as our data on men are restricted to those that reported an ongoing partnership with a 15–24 year old woman 
and data on partners older than 24 are therefore excluded.
^
n = 1072 for this variable due to missing data on age at first sex or the age of participants’ first partner.
#
The three, separate age-disparate measures for young women are not mutually exclusive. They all include data on most recent partnerships.
1
The first age-disparate measure identifies women who reported an age-disparity in their most recent partnership.
2
The second age-disparate measure identifies women who reported an age-disparity in any of their three most recent partnerships, including their 
first.
3
The third age-disparate measure identifies woman who reported an age-disparity in their first-ever partnership or any of their three most recent 
partnerships.
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Table 2
The association between the three measures of age-disparate partnerships and HIV status among 15–24 year 
old women in bivariate and multiple logistic regression analyses.
(1)
HIV+
% [95%CI]
(2)
HIV+
OR [95%CI]
(3)
HIV+
aOR [95%CI]
Data included in analysis
Last partner (N=1438)a
Age-similar 25 [22–29] ref ref
Age-disparate1 36 [31–41] 1.62***[1.26–2.09] 1.51***[1.15–1.99]
Difference^ 11***
Last 3 partners (N=1459)b
Age-similar 25 [22–28] ref ref
Age-disparate2 37 [32–42] 1.75***[1.35–2.28] 1.58***[1.20–2.09]
Difference^ 12***
1st or last 3 partners (N=1072)c
Age-similar 22 [18–26] ref ref
Age-disparate3 35 [32–42] 1.92***[1.41–2.61] 1.56**[1.08–2.26]
Difference^ 13***
Notes:
***p<0.01,
**p<0.05,
*p<0.1.
a
The sample size of N=1438 was reached after the following exclusions had been made from the HIPPS sample of 2224 women aged 15-to-24 
years old: 667 women reported never having had sex; 1 woman was missing data on her partner’s age; 118 women reported a recent partnership in 
which the start date of the partnership occurred after the reported date of an HIV-positive test.
b
The sample size of N=1459 was reached after the following exclusions had been made from the HIPPS sample of 2224 women aged 15-to-24 
years old: 667 women reported never having had sex; 1 woman was missing data on her partner’s age; 97 women reported only a partnership(s) in 
which the start date of the partnership(s) occurred after the reported date of an HIV-positive test.
c
The sample size of N=1072 was reached after the following exclusions had been made from the HIPPS sample of 2224 women aged 15-to-24 
years old: 667 women reported never having had sex; 414 participants were missing data on first-ever partnerships, participants’ age at first sex, or 
the partner’s age; 71 women reported only a partnership(s) in which the start date of the partnership(s) occurred after the reported date of an HIV-
positive test.
1
The first age-disparate measure identifies women who reported an age-disparity in their most recent partnership.
2
The second age-disparate measure identifies women who reported an age-disparity in any of their three most recent partnerships, including their 
first.
3
The third age-disparate measure identifies woman who reported an age-disparity in their first-ever partnership or any of their three most recent 
partnerships.
^p-values for the differences reported in column 1 are based on two sample equality of proportions tests.
aOR: Adjusted odds ratios from multiple logistic regression models controlling for age of the woman (years); education (Grade 12 completed or 
not); having always lived in the area; household asset index (count of assets from 0–14); monthly household income; number of lifetime sexual 
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partners; HIV-testing history (no, yes) and number of useful sources of HIV information exposed to during the previous 12 months (0–16). 95%CI: 
95% Confidence interval.
ref: the reference category in all logistic regression analyses is age-similar partnerships (i.e., partnership age-difference ≤4 years).
See Supplemental Digital Content 1, Table S1, for the full multiple logistic regression models presented in column 3, including coefficients for the 
control variables in each model.
J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2019 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Maughan-Brown et al. Page 16
Table 3
Multiple logistic regression models of HIV status and detectable HIV viral load among men in partnerships 
with 15–24 year old women.
(1) (2) (3) (4)
HIV+ HIV+ HIV+ with viral
load≥1000
copies/mL
HIV+ with
viral
load≥1000
copies/mL
aOR
(95%CI)
aOR
(95%CI)
aOR
(95%CI)
aOR
(95%CI)
Partnership age-gap (ref:≤4 yrs)
≥5 years 2.92*** na 2.05*** na
(1.83 – 4.67) na (1.30 – 3.24) na
5–9 years na 2.29*** na 2.01**
na (1.37 – 3.82) na (1.18 – 3.43)
10+ years na 5.39*** na 2.17**
na (2.54 – 11.44) na (1.01 – 4.66)
Age of female partner (years)^ 1.17*** 1.17*** 1.20*** 1.20***
(1.08 – 1.26) (1.08 – 1.26) (1.10 – 1.30) (1.10 – 1.30)
Observations 1,229 1,229 1,229 1,229
Notes:
***p<0.01,
**p<0.05,
*p<0.1.
Adjusted odds ratios with 95% CI in parentheses.
Robust standard errors, clustered at the enumeration area level.
^
The age of women in the reported partnerships is measured in years (15–24).
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